07:37 AM EDT, 05/30/2025 (MT Newswires) -- BioVaxys Technology Corp. ( BVAXF ) announced overnight Thursday that it and Horizon Technology Finance Corporation have executed a follow-on amendment to the Asset Purchase Agreement dated February 11th, 2024, for acquiring the entire portfolio of assets and intellectual property based on the DPXTM immune educating platform technology developed by Canadian biotechnology company, IMV Inc.